企業プロフィール
Indaptus Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- INDP
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.00 USD (-6.54%)
終値
最終更新: 2026年8月17日
243M USD
時価総額
株価変動の要因
As of Aug 17, 2026, INDP closed down 6.54% at $1.00. No new same-company headline was identified in the current news window.
企業概要
Immunotherapy Research Company
Indaptus Therapeutics developed the Decoy platform, a systemic immunotherapy approach designed to activate multiple innate and adaptive immune pathways.
Decoy20
Decoy20 is a killed, attenuated bacterial product intended to stimulate broad antitumor immunity. Indaptus has discontinued enrollment and currently has no patients in active Decoy20 clinical studies.
Strategic Review
The company has reduced Decoy20 development activities and is evaluating research collaborations, strategic investments, acquisitions, and other potential business combinations.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。